Cargando…

Pharmacogenetic information in Swiss drug labels – a systematic analysis

Implementation of pharmacogenetics (PGx) and individualization of drug therapy is supposed to obviate adverse drug reactions or therapy failure. Health care professionals (HCPs) use drug labels (DLs) as reliable information about drugs. We analyzed the Swiss DLs to give an overview on the currently...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeiziner, C., Suter, K., Wernli, U., Barbarino, J. M., Gong, L., Whirl-Carrillo, M., Klein, T. E., Szucs, T. D., Hersberger, K. E., Meyer zu Schwabedissen, H. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292148/ https://www.ncbi.nlm.nih.gov/pubmed/33070160 http://dx.doi.org/10.1038/s41397-020-00195-4

Ejemplares similares

HLA‐associated adverse drug reactions ‐ scoping review
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
por: Jeiziner, Chiara, et al.
Publicado: (2022)

Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service
por: Jeiziner, Chiara, et al.
Publicado: (2023)

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept
por: Stäuble, Céline K., et al.
Publicado: (2021)

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
por: Bollinger, Anna, et al.
Publicado: (2023)

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
por: Stäuble, Céline K., et al.
Publicado: (2022)

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

PharmGKB: A worldwide resource for pharmacogenomic information
por: Barbarino, Julia M., et al.
Publicado: (2018)

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy
por: Wiss, Florine M., et al.
Publicado: (2023)

The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge
por: Hernandez-Boussard, Tina, et al.
Publicado: (2008)

Development of the Swiss Database for dosing medicinal products in pediatrics
por: Tilen, Romy, et al.
Publicado: (2021)

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
por: Caudle, Kelly E., et al.
Publicado: (2017)

Pharmacogenetic Analysis of Voriconazole Treatment in Children
por: Tilen, Romy, et al.
Publicado: (2022)

Pharmacogenetic information for patients on drug labels
por: Haga, Susanne B, et al.
Publicado: (2014)

Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
por: Wittwer, Nina L, et al.
Publicado: (2022)

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
por: Caudle, Kelly E., et al.
Publicado: (2019)

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population
por: Verma, Shefali S., et al.
Publicado: (2022)

Variant Interpretation in Current Pharmacogenetic Testing
por: Luvsantseren, Sally, et al.
Publicado: (2020)

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

PGxMine: Text mining for curation of PharmGKB
por: Lever, Jake, et al.
Publicado: (2020)

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene
por: Stäuble, Céline K., et al.
Publicado: (2022)

Adherence counseling during patient contacts in swiss community pharmacies
por: Boeni, Fabienne, et al.
Publicado: (2015)

Pharmaceutical Discharge Management: Implementation in Swiss Hospitals Compared to International Guidelines
por: Studer, Helene, et al.
Publicado: (2021)

Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
por: Caudle, Kelly E., et al.
Publicado: (2014)

Expression and Function of Organic Anion Transporting Polypeptides in the Human Brain: Physiological and Pharmacological Implications
por: Schäfer, Anima M., et al.
Publicado: (2021)

Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?
por: Studer, Helene, et al.
Publicado: (2020)

Swiss Community Pharmacies' on the Web and Pharmacists' Experiences with E-commerce: Longitudinal study and Internet-based questionnaire survey
por: Zehnder, Simon, et al.
Publicado: (2004)

Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot
por: Stämpfli, Dominik, et al.
Publicado: (2023)

SwissPK(cdw) – A clinical data warehouse for the optimization of pediatric dosing regimens
por: Goers, Roland, et al.
Publicado: (2021)

No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA
por: Vizeli, Patrick, et al.
Publicado: (2017)

Dispensing of Prescribed Medicines in Swiss Community Pharmacies-Observed Counselling Activities
por: Maes, Karen A., et al.
Publicado: (2018)

Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report
por: Meyer zu Schwabedissen, Henriette E, et al.
Publicado: (2014)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

Revisiting Secondary Information Related to Pharmacogenetic Testing
por: Haga, Susanne B.
Publicado: (2021)

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018)

An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
por: Whirl‐Carrillo, Michelle, et al.
Publicado: (2021)

Patient Knowledge about Oral Anticoagulation Therapy Assessed during an Intermediate Medication Review in Swiss Community Pharmacies
por: Metaxas, Corina, et al.
Publicado: (2020)

Clinical relevance of St. John's wort drug interactions revisited
por: Nicolussi, Simon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_umca4tbei91dovg9f5lm9ropoh